SCHEMBL17849080

SCHEMBL17849080

Brc1cccc2cc3cc4cc5cc6ccccc6cc5cc4cc3cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 3/20 0.44
GAA P10253 2/20 0.44
HSD17B10 Q99714 5/20 0.42
HIF1A Q16665 3/20 0.42
CYP1B1 Q16678 1/20 0.42
CYP2A6 P11509 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CASP1 P29466 2/20 0.39
CASP7 P55210 2/20 0.39
CYP3A4 P08684 1/20 0.39
ALOX15 P16050 1/20 0.39
HBB P68871 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP1A2 P05177 3/20 0.39
AHR P35869 2/20 0.39
ERBB2 P04626 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1873234 1.00 ALDH1A1 (0.44) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL17849090 1.00 ALDH1A1 (0.44) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL31364317 1.00 ALDH1A1 (0.44) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL30149559 1.00 ALDH1A1 (0.44) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL2407961 0.98 ALDH1A1 (0.45) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL29388401 0.98 ALDH1A1 (0.45) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL11287037 0.94 ALDH1A1 (0.48) ALDH1A1KDM4EGAAHSD17B10HIF1A
Fluoride SCHEMBL28034450 0.93 ALDH1A1 (0.42) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL28021465 0.91 ALDH1A1 (0.50) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL29971666 0.90 ALDH1A1 (0.43) ALDH1A1KDM4EGAAHSD17B10HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10752730-B2 Quantitative intramolecular fission in oligoacenes, materials, and methods of use thereof THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2020-08-25 US disclosed
US-20180258217-A1 QUANTITATIVE INTRAMOLECULAR FISSION IN OLIGOACENES, MATERIALS, AND METHODS OF USE THEREOF UNITED STATES DEPARTMENT OF ENERGY 2018-09-13 US disclosed
WO-2016100754-A1 QUANTITATIVE INTRAMOLECULAR FISSION IN OLIGOACENES, MATERIALS, AND METHODS OF USE THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2016-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10752730-B2 Quantitative intramolecular fission in oligoacenes, materials, and methods of use thereof SPIN1, SPIN3, ESPL1 ALDH1A1 3818/4885KDM4E 4485/4885GAA 4697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.